Jay Mohr is an experienced C-level executive in the biopharma industry, focusing on cellular and hematology therapies. Currently serving as General Partner at NYBC Ventures and EVP, Chief Business Officer at the New York Blood Center, they lead business development and venture investments in blood-related fields. Mohr co-founded Gloucester Pharmaceuticals, where they successfully led the company to FDA approval for its lead asset, resulting in a significant acquisition by Celgene. Their previous roles include President at Dirigo Therapeutics and executive positions at Serono, Inc. and Variagenics, Inc. Mohr holds a BA in Economics and German from Vanderbilt University and an MBA from The Wharton School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices